vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and JOINT Corp (JYNT). Click either name above to swap in a different company.
JOINT Corp is the larger business by last-quarter revenue ($15.2M vs $9.2M, roughly 1.6× Foghorn Therapeutics Inc.). JOINT Corp runs the higher net margin — 6.5% vs -234.3%, a 240.8% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 3.1%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -28.6%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
The Joint Corp is a leading operator and franchisor of chiropractic care clinics primarily serving the U.S. market. It offers accessible, affordable routine chiropractic services, membership-based care plans, and caters to consumers seeking non-invasive musculoskeletal pain management and wellness support.
FHTX vs JYNT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $15.2M |
| Net Profit | $-21.7M | $991.1K |
| Gross Margin | — | 81.4% |
| Operating Margin | -258.2% | 4.9% |
| Net Margin | -234.3% | 6.5% |
| Revenue YoY | 223.8% | 3.1% |
| Net Profit YoY | -11.1% | 5510.5% |
| EPS (diluted) | $-0.35 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $15.2M | ||
| Q3 25 | $8.2M | $13.4M | ||
| Q2 25 | $7.6M | $13.3M | ||
| Q1 25 | $6.0M | $13.1M | ||
| Q4 24 | $2.9M | $14.7M | ||
| Q3 24 | $7.8M | $30.2M | ||
| Q2 24 | $6.9M | $30.3M | ||
| Q1 24 | $5.0M | $29.7M |
| Q4 25 | $-21.7M | $991.1K | ||
| Q3 25 | $-15.8M | $855.0K | ||
| Q2 25 | $-17.9M | $93.4K | ||
| Q1 25 | $-18.8M | $967.8K | ||
| Q4 24 | $-19.5M | $17.7K | ||
| Q3 24 | $-19.1M | $-3.2M | ||
| Q2 24 | $-23.0M | $-3.6M | ||
| Q1 24 | $-25.0M | $947.0K |
| Q4 25 | — | 81.4% | ||
| Q3 25 | — | 80.1% | ||
| Q2 25 | — | 79.1% | ||
| Q1 25 | — | 77.3% | ||
| Q4 24 | — | 78.4% | ||
| Q3 24 | — | 90.7% | ||
| Q2 24 | — | 90.7% | ||
| Q1 24 | — | 90.9% |
| Q4 25 | -258.2% | 4.9% | ||
| Q3 25 | -226.9% | 1.2% | ||
| Q2 25 | -279.2% | -8.6% | ||
| Q1 25 | -385.0% | -5.2% | ||
| Q4 24 | -840.5% | 5.5% | ||
| Q3 24 | -305.5% | -1.6% | ||
| Q2 24 | -386.6% | -5.9% | ||
| Q1 24 | -558.3% | -1.4% |
| Q4 25 | -234.3% | 6.5% | ||
| Q3 25 | -194.4% | 6.4% | ||
| Q2 25 | -237.3% | 0.7% | ||
| Q1 25 | -316.4% | 7.4% | ||
| Q4 24 | -682.9% | 0.1% | ||
| Q3 24 | -244.9% | -10.5% | ||
| Q2 24 | -333.6% | -11.9% | ||
| Q1 24 | -495.4% | 3.2% |
| Q4 25 | $-0.35 | $0.06 | ||
| Q3 25 | $-0.25 | $0.06 | ||
| Q2 25 | $-0.28 | $0.01 | ||
| Q1 25 | $-0.30 | $0.06 | ||
| Q4 24 | $-0.23 | $0.01 | ||
| Q3 24 | $-0.31 | $-0.21 | ||
| Q2 24 | $-0.45 | $-0.24 | ||
| Q1 24 | $-0.59 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $23.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $15.1M |
| Total Assets | $198.1M | $61.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $23.6M | ||
| Q3 25 | $89.3M | $29.7M | ||
| Q2 25 | $72.6M | $29.8M | ||
| Q1 25 | $61.0M | $21.9M | ||
| Q4 24 | $55.5M | $25.1M | ||
| Q3 24 | $57.7M | $20.7M | ||
| Q2 24 | $138.9M | $17.5M | ||
| Q1 24 | $79.3M | $18.7M |
| Q4 25 | $-108.5M | $15.1M | ||
| Q3 25 | $-89.7M | $22.7M | ||
| Q2 25 | $-76.7M | $23.2M | ||
| Q1 25 | $-61.7M | $22.8M | ||
| Q4 24 | $-45.5M | $20.7M | ||
| Q3 24 | $-28.3M | $20.5M | ||
| Q2 24 | $-14.3M | $23.2M | ||
| Q1 24 | $-97.5M | $26.2M |
| Q4 25 | $198.1M | $61.0M | ||
| Q3 25 | $205.0M | $69.4M | ||
| Q2 25 | $226.2M | $73.2M | ||
| Q1 25 | $258.7M | $80.1M | ||
| Q4 24 | $284.0M | $83.2M | ||
| Q3 24 | $308.4M | $79.6M | ||
| Q2 24 | $328.6M | $82.4M | ||
| Q1 24 | $255.0M | $85.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $1.8M |
| Free Cash FlowOCF − Capex | — | $334.7K |
| FCF MarginFCF / Revenue | — | 2.2% |
| Capex IntensityCapex / Revenue | 0.0% | 9.9% |
| Cash ConversionOCF / Net Profit | — | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $1.8M | ||
| Q3 25 | $-18.9M | $1.8M | ||
| Q2 25 | $-21.0M | $868.6K | ||
| Q1 25 | $-24.0M | $-3.7M | ||
| Q4 24 | $-24.5M | $9.4M | ||
| Q3 24 | $-21.0M | $3.4M | ||
| Q2 24 | $-25.5M | $-973.5K | ||
| Q1 24 | $-29.3M | $2.8M |
| Q4 25 | — | $334.7K | ||
| Q3 25 | — | $1.5M | ||
| Q2 25 | $-21.0M | $363.6K | ||
| Q1 25 | $-24.0M | $-4.0M | ||
| Q4 24 | $-25.0M | $8.2M | ||
| Q3 24 | $-21.3M | $3.2M | ||
| Q2 24 | $-25.6M | $-1.2M | ||
| Q1 24 | $-29.4M | $2.4M |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 10.9% | ||
| Q2 25 | -278.2% | 2.7% | ||
| Q1 25 | -403.2% | -30.8% | ||
| Q4 24 | -875.3% | 55.9% | ||
| Q3 24 | -273.0% | 10.6% | ||
| Q2 24 | -371.0% | -4.1% | ||
| Q1 24 | -583.1% | 8.1% |
| Q4 25 | 0.0% | 9.9% | ||
| Q3 25 | 0.0% | 2.4% | ||
| Q2 25 | 0.3% | 3.8% | ||
| Q1 25 | 0.5% | 2.5% | ||
| Q4 24 | 16.8% | 8.1% | ||
| Q3 24 | 4.0% | 0.8% | ||
| Q2 24 | 0.2% | 0.9% | ||
| Q1 24 | 2.0% | 1.3% |
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | 2.07× | ||
| Q2 25 | — | 9.30× | ||
| Q1 25 | — | -3.82× | ||
| Q4 24 | — | 532.98× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FHTX
Segment breakdown not available.
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
